Banking (prudential standard) determination No. 2 of 2015 - Prudential Standard APS 330 - Public Disclosure

---

meta-content-style-type: text/css meta-content-type: application/xhtml+xml; charset=utf-8 meta-generator: Aspose.Words for .NET 20.2

?xml version="1.0" encoding="utf-8" standalone="no"?>

View image in the official source

Banking (prudential standard) determination No. 2 of 2015

Prudential Standard APS 330 Public Disclosure

Banking Act 1959

 

I, Wayne Byres, delegate of APRA:

 

(a)                under subsection 11AF(3) of the Banking Act 1959 (the Act) REVOKE Banking (prudential standard) determination No. 11 of 2014, including Prudential Standard APS 330 Public Disclosure made under that Determination; and

(b)               under subsection 11AF(1) of the Act DETERMINE Prudential Standard APS 330 Public Disclosure, in the form set out in the Schedule, which applies to ADIs and authorised NOHCs to the extent provided in paragraphs 2 to 4 of the prudential standard.

 

This instrument takes effect on 1 July 2015.

 

Dated: 4 May 2015

 

[Signed]

 

 

Wayne Byres

Chairman

APRA

 

Interpretation

In this Determination:

ADI has the meaning given in section 5 of the Act.

APRA means the Australian Prudential Regulation Authority.

authorised NOHC has the meaning given in section 5 of the Act.

•                 Schedule

 

Prudential Standard APS 330 Public Disclosure comprises the 63 pages commencing on the following page.

 

View image in the official source  

 

Prudential Standard APS 330

Public Disclosure

Table of contents

Authority

Application

Interpretation

Key principles

Definitions

Capital disclosure requirements

Risk exposure and assessment disclosures

Leverage ratio disclosures

Remuneration disclosures

Disclosures for the identification of potential G-SIBs

General requirements

Attachments

 

Attachment A — Capital disclosure template

Attachment B — Main features of capital instruments

Attachment C — Risk exposures and assessment (all ADIs)

Attachment D — Risk exposure and assessment (ADIs with IRB and AMA approval)

Attachment E — Leverage ratio disclosure requirements

Attachment F — Liquidity Coverage Ratio disclosure template

Attachment G — Remuneration

Attachment H — Disclosures for the identification of potential G-SIBs

Attachment I — Frequency and timing of disclosure requirements

Authority

1. This Prudential Standard is made under section 11AF of the Banking Act 1959 (the Banking Act).

Application

2.             This Prudential Standard applies to all locally incorporated authorised deposit-taking institutions (ADIs) other than purchased payment facility providers (PPF providers).

3.             Where a locally incorporated ADI is a subsidiary of an authorised non-operating holding company (authorised NOHC), the authorised NOHC must ensure that the requirements in this Prudential Standard are met on a Level 2 basis.

4.             Where an ADI has no authorised NOHC, or any other subsidiaries other than those making up an Extended Licensed Entity (ELE), the ADI must comply with this Prudential Standard on a Level 1 basis; otherwise, a reference to an ADI in this Prudential Standard is a reference to the group of which the ADI is a member on a Level 2 basis. An ADI within a Level 2 group will not be required to fulfil the requirements set out in this Prudential Standard on a Level 1 basis, unless specifically required to do so by APRA.

Interpretation

5.             Terms that are defined in Prudential Standard APS 001 Definitions (APS 001) appear in bold the first time they are used in this Prudential Standard.

6.             Where this Prudential Standard provides for APRA to exercise a power or discretion, this power or discretion will be exercised in writing.

Key principles

7.             An ADI must make accurate, high quality and timely public disclosures of information on its:

(a)          risk profile;

(b)          risk management;

(c)          capital adequacy;

(d)          capital instruments;

(e)          remuneration practices; and,

where applicable, on its:

(f)           leverage ratio;

(g)          liquidity coverage ratio (LCR); and

(h)          global systemically important bank (G-SIB) indicators,

so as to contribute to the transparency of financial markets and to enhance market discipline.

8.             An ADI’s public disclosures must be consistent with the scope and complexity of its operations and the sophistication of its risk management systems and processes.

Definitions

9.             For the purposes of this Prudential Standard:

(a)          ‘annual directors’ report’ is the directors’ report for a financial year required under the Corporations Act 2001 (Corporations Act);

(b)          ‘annual financial report’ has the meaning given in the Corporations Act;

(c)          ‘AT1’ refers to Additional Tier 1 Capital;

(d)          ‘the Basel Committee’ refers to the Basel Committee on Banking Supervision;

(e)          ‘the Basel II framework’ refers to the document International Convergence of Capital Measurement and Capital Standards: A Revised Framework, Comprehensive Version¸ June 2006, published by the Basel Committee;

(f)           ‘Basel III’ refers to the document Basel III: A global regulatory framework for more resilient banks and banking systems, revised version, June 2011, published by the Basel Committee;

(g)          ‘capital disclosures’ means the disclosures in Attachments A and B;

(h)          ‘capital disclosure template’ means Table 1 in Attachment A;

(i)            ‘CET1’ refers to Common Equity Tier 1 Capital;

(j)            ‘directors’ report’ has the meaning given in the Corporations Act;

(k)          ‘financial report’ is as defined in the Corporations Act;

(l)            ‘financial statement’ is as defined in the Corporations Act;

(m)        ‘disclosures for the identification of potential G-SIBs’ means the disclosures in Attachment H;

(n)          ‘HQLA’ means high-quality liquid assets determined in accordance with APS 210 Liquidity (APS 210);

(o)          ‘IRB ADI’ is an ADI with approval from APRA to use the internal ratings-based (IRB) approach to credit risk;

(p)          ‘LCR’ is as defined in APS 210;

(q)          ‘LCR ADI’ is an ADI classified as an LCR ADI under APS 210 but does not include a foreign ADI;

(r)           ‘LCR disclosures’ means the disclosures in Attachment F;

(s)           ‘leverage ratio’ is as defined in Prudential Standard APS 110 Capital Adequacy (APS 110);

(t)            ‘leverage ratio disclosures’ means the disclosures in Attachment E;

(u)          ‘main features template’ means Table 2 in Attachment B;

(v)          ‘prudential disclosures’ means the disclosures in Attachments A to H and includes the Regulatory Capital reconciliation prepared in accordance with paragraph 12 below;

(w)        ‘Regulatory Capital’ is as defined in Prudential Standard APS 111 Capital Adequacy: Measurement of Capital (APS 111);

(x)          ‘Regulatory Capital reconciliation’ means the document to be prepared in accordance with paragraph 12 below;

(y)          ‘risk exposure and assessment’ means the disclosures in Attachments C and D;

(z)          ‘remuneration disclosures’ means the disclosures in Attachment G;

(aa)       ‘T1’ refers to Tier 1 Capital; and

(bb)      ‘T2’ refers to Tier 2 Capital.

Capital disclosure requirements

10.         All ADIs to which this Prudential Standard applies must make the disclosures in Attachments A and B and must disclose the full terms and conditions of instruments included in their Regulatory Capital in accordance with the provisions of this Prudential Standard.

11.         In making the disclosures in Attachment A, until 1 January 2018 an ADI must include a statement that it is using the post 1 January 2018 capital disclosure template because it is fully applying the Basel III regulatory adjustments as implemented by APRA.

12.         All ADIs must prepare and disclose a Regulatory Capital reconciliation. This is a full reconciliation of all Regulatory Capital elements to the ADI’s balance sheet in its audited financial statements. The reconciliation must:

(a)          include the reported balance sheet under the regulatory scope of consolidation;

(b)          include a list of legal entities that are included within the accounting scope of consolidation but excluded from the regulatory scope of consolidation and vice-versa. Any entities included in both the regulatory and accounting scope of consolidation where the method of consolidation differs must be listed separately with an explanation of the differences between consolidation methods;

(c)          expand each line of the balance sheet under the regulatory scope of consolidation to display all components of the capital disclosure template; and

(d)          map each of the components disclosed in (c) to the capital disclosure template by reference to each line item.

13.         For each entity listed in accordance with paragraph 12(b) above, an ADI must disclose:

(a)          total balance sheet assets;

(b)          total balance sheet liabilities; and

(c)          the principal activities of the entity.

14.         In the case of a Level 2 group, the Regulatory Capital reconciliation must also include:

(a)           details of any restrictions, or other major impediments, on the transfer of funds or Regulatory Capital within the group; and

(b)           the name of the head of the Level 2 group to which this Prudential Standard applies.

Risk exposure and assessment disclosures

15.         Attachment C sets out the risk exposure and assessment disclosures that must be made by all ADIs to which this Prudential Standard applies.

16.         Attachment D sets out the additional risk exposure and assessment disclosures that must be made by a locally incorporated ADI that has approval from APRA to use the IRB approach to credit risk and the AMA approach to operational risk.

Leverage ratio disclosures

17.         An IRB ADI must make the leverage ratio disclosures in Attachment E and the disclosures in paragraph 47.

 

Liquidity Coverage Ratio disclosures

18.         An ADI classified as an LCR ADI[1] for the purposes of APS 210 must make the LCR disclosures required in Attachment F.

19.         An LCR ADI must provide sufficient qualitative discussion to facilitate users’ understanding of the LCR disclosures required in Attachment F. This may include discussion of:

(a)          the main drivers of the LCR results and the evolution of the contribution of inputs to the LCR’s calculation over time;

(b)          intra-period changes as well as changes over time;

(c)          the composition of its HQLA;

(d)          concentration of funding sources;

(e)          derivative exposures and potential collateral calls;

(f)           currency mismatch in the LCR;

(g)          where appropriate, the degree of centralisation of liquidity management and interaction between the Level 2 group’s units; and

(h)          other inflows and outflows in the LCR calculation that are not captured in the LCR disclosure template but which the ADI considers to be relevant for its liquidity profile.

Remuneration disclosures

20.         An ADI must make the remuneration disclosures in Attachment G.

21.         For the purposes of the remuneration disclosures:

(a)          a ‘senior manager’ refers to each responsible person included in an ADI’s Remuneration Policy under Prudential Standard CPS 510 Governance (CPS 510); and

(b)          ‘material risk-taker’ refers to persons included in an ADI’s Remuneration Policy under CPS 510.

Disclosures for the identification of potential G-SIBs

22.         If required by APRA, an ADI must make the disclosures for the identification of potential G-SIBs in Attachment H[2].

General requirements

23.         If APRA is not satisfied that the adequacy or quality of an ADI’s prudential disclosures is consistent with the principles set out in paragraphs 7 and 8 above or the requirements in paragraph 28 below, APRA may require the ADI to rectify the disclosures or to disclose further information. 

24.         APRA may require an ADI whose risk management practices, capital adequacy position, LCR position, leverage ratio or remuneration practices have changed materially, or are subject to ongoing rapid change, to vary the content and/or frequency of its prudential disclosures.

25.         APRA may require a foreign-owned ADI that has IRB and/or AMA approval to increase the content and/or frequency of its prudential disclosures, taking account of:

(a)          the significance of the ADI in the context of the Australian financial system;

(b)          the significance of the ADI in its global banking group; and

(c)          the quality of the disclosure of capital adequacy information by the overseas parent in its home jurisdiction.

Disclosure policy

26.         An ADI must have a formal policy relating to its prudential disclosures approved by the Board that addresses the ADI’s approach to determining the content of its prudential disclosures and the internal controls over the disclosure process.

27.         An ADI must implement a process for assessing the appropriateness and accuracy of its prudential disclosures, including their validation and frequency. This must be summarised in the ADI’s prudential disclosures policy.

28.         An ADI must take reasonable steps to ensure that its prudential disclosures reflect its actual risk profile and are consistent with the manner in which its Board and senior management assess and manage its risks. Where the minimum requirements for prudential disclosures set out in this Prudential Standard do not adequately capture this, the ADI must disclose additional information.

Verification of disclosures

29.         An ADI must ensure that prudential disclosures are appropriately verified and must take steps necessary to ensure their reliability.

30.         An ADI must ensure that its prudential disclosures are consistent with information that has been subject to review by an external auditor and that is lodged or published elsewhere or that has been already supplied to APRA.

31.         APRA may require an ADI to commission an independent audit of its prudential disclosures. This may include where APRA has reason to believe that the information being disclosed is incorrect or misleading.

Medium of disclosures

32.         An ADI that has its own website must include a ‘Regulatory Disclosures’ section on its website.

33.         If:

(a)          for paragraphs 34 and 35 below, an ADI is not required to lodge a financial report or directors’ report under the Corporations Act; or

(b)          for paragraphs 34, 35 and 36 below, an ADI does not have its own website,

the ADI must obtain APRA’s approval for alternative publication arrangements.

34.         The disclosures required in Attachment A, the Regulatory Capital reconciliation and, if applicable, Attachment E[3] and/or Attachment F must be included in:

(a)          an ADI’s financial report; or

(b)          an ADI’s directors’ report; or

(c)          other information accompanying an ADI’s financial report; or

(d)          the Regulatory Disclosures section on the ADI’s website, provided that the financial report, directors’ report or other information accompanying the financial report includes a link to these completed disclosures[4].

35.         The disclosures required in Attachment B and the full terms and conditions of Regulatory Capital instruments must be published in full in the Regulatory Disclosures section on an ADI’s website. They must also be published in full, or a link to the disclosures on the Regulatory Disclosures section of the ADI’s website must be included in:

(a)          an ADI’s financial report; or

(b)          an ADI’s director’s report; or

(c)          other information accompanying an ADI’s financial report.

36.         The disclosures required in Attachments C, D and G must be published in full in the Regulatory Disclosures section on an ADI’s website[5].

37.         If an ADI is required to prepare and lodge a ‘Remuneration report’ in accordance with the Corporations Act, it may include its remuneration disclosures in that report provided it clearly distinguishes between the disclosures required under the Corporations Act and those required under this Prudential Standard.

38.         If applicable, the disclosures required in Attachment H must be included in:

(a)          an ADI’s annual financial report; or

(b)          the Regulatory Disclosures section on an ADI’s website, provided that the ADI includes a direct link to the published disclosures on its website in the first annual financial report lodged under the Corporations Act after the date the disclosures are published on the ADI’s website.

Frequency and timing of disclosures

39.         If:

(a)          for the purposes of paragraphs 40, 41, 43 and 46 below, an ADI is not required to lodge financial reports under the Corporations Act; or

(b)          for the purposes of paragraph 49 and 51 below, an ADI is not required to lodge an annual financial report under the Corporations Act,

the ADI must obtain APRA’s approval for alternative timing for the disclosures.

40.         The disclosures required in Attachment A, the Regulatory Capital reconciliation and, if applicable, Attachment E and /or Attachment F must be made as at the balance sheet date of the corresponding financial report. The disclosures must be made with the same frequency as, and concurrent with, the lodgement of the ADI’s financial reports under the Corporations Act[6].

41.         The disclosures required in Attachment B and the full terms and conditions of Regulatory Capital instruments must be published continuously. The disclosures must be updated within seven calendar days if the following occurs:

(a)          a new capital instrument is issued and included in Regulatory Capital; or

(b)          a capital instrument is redeemed, converted into Common Equity Tier 1 Capital, written off or otherwise changes in nature.

42.         The disclosures required in Attachment C must be published on a quarterly basis. For comparison purposes, all disclosures in Attachment C (except for the initial disclosures) must be published together with the immediately preceding disclosures for Attachment C.

43.         The disclosures in Attachment C must be published:

(a)          concurrently with the lodgement of an ADI’s financial reports under the Corporations Act[7]; and

(b)          for any quarterly period that does not coincide with the lodgement of an ADI’s financial report under the Corporations Act, within 40 business days after the end of the period to which they relate.

44.         The qualitative disclosures required in Attachment D must be published on an annual basis.

45.         The quantitative disclosures required in Attachment D must be published on a semi-annual basis. For comparison purposes, all quantitative disclosures for Attachment D (except initial disclosures) must be published together with the immediately preceding quantitative disclosures for Attachment D.

46.         The disclosures in Attachment D must be made concurrently with the lodgement of an ADI’s financial reports under the Corporations Act[8]. 

47.         If required under paragraph 17, in addition to the requirements in paragraph 40, an IRB ADI must make the following quantitative disclosures required in Attachment E on a quarterly basis, commencing no later than three months after the commencement of this Prudential Standard:

(a)          Tier 1 Capital (refer to item 20 in Table 18);

(b)          Total exposures (refer to item 21 in Table 18); and

(c)          leverage ratio (refer to item 22 in Table 18)[9].

48.         The disclosures required to be made under paragraph 47 must be published together with the figures for the three previous quarterly periods[10]. For any quarterly period that does not coincide with the lodgement of an ADI’s financial report under the Corporations Act, the disclosures must be published within 40 business days after the end of the period to which they relate.

49.         The remuneration disclosures required in Attachment G must be published with the same frequency as, and within three months of lodgement of, the ADI’s annual financial report under the Corporations Act[11].

50.         After the initial remuneration disclosure, all subsequent quantitative remuneration disclosures must be published together with the quantitative remuneration disclosures for the previous annual period in accordance with the provisions in this Prudential Standard.

51.         If required under paragraph 22, an ADI must:

(a)          make the disclosures in Attachment H as at the balance sheet date of the corresponding annual financial report[12]; and

(b)          publish these disclosures not later than 31 July following the balance sheet date on which the disclosures are based.

52.         The requirements for the frequency and timing of disclosures in paragraphs 40 to 51 are summarised in Attachment I.  

Non-regulatory ratios

53.         If an ADI publishes capital adequacy ratios:

(a)          that are calculated other than in accordance with APS 110; or

(b)          that involve components of Regulatory Capital that are not defined in APS 111 (including terms such as ‘Equity Tier 1’, ‘Core Tier 1’ or ‘Tangible Common Equity’),

such publication must include a comprehensive explanation of how these ratios are calculated and details of the elements of capital used. This requirement applies regardless of whether the capital ratios are prudential disclosures made in accordance with this Prudential Standard.

Public availability of disclosures

54.         Irrespective of the medium of publication, an ADI must make publicly available its prudential disclosures for a minimum period of 12 months.

Materiality

55.         An ADI, in making a disclosure, must decide which prudential disclosures are material. An ADI is not required to make a prudential disclosure if it considers the matter to be disclosed to be immaterial. Information is regarded as material if its omission or misstatement could change or influence the assessment or decision of a user relying on that information for the purpose of making economic decisions. More generally, an ADI must have regard to materiality as applied in the context of its other public disclosures (for instance, as required under the Corporations Act).

Proprietary, confidential and personal information

56.         Proprietary information encompasses information that, if shared with competitors, would render an ADI’s investment in its products/systems less valuable by undermining its competitive position. Confidential information is that which an ADI possesses about customers or other persons that is confidential, being provided under the terms of a legal agreement or counterparty relationship. Personal information is as defined in the Privacy Act 1988.

57.         Disclosure of certain items of information required by this Prudential Standard may prejudice the position of an ADI or any other person by making public information that is proprietary, confidential or personal in nature. In such circumstances, the ADI may elect not to disclose this information and to instead disclose more general information about the subject matter of the requirement, together with the fact that, and the reason why, the specific items of information have not been disclosed. Under paragraph 23 above, APRA may require the ADI to rectify the disclosures or to disclose further information if APRA is not satisfied with the adequacy or quality of the disclosures. 

Adjustments and exclusions

58.         APRA may, by notice, adjust or exclude a specific prudential requirement in this Prudential Standard in relation to an ADI[13].

Attachment A

Capital disclosure template

1. An ADI must complete and disclose Table 1 to the extent applicable.

Table 1: Capital disclosure template

 

• Common Equity Tier 1 capital: instruments and reserves A$m
• 1 Directly issued qualifying ordinary shares (and equivalent for mutually-owned entities) capital
• 2 Retained earnings
• 3 Accumulated other comprehensive income (and other reserves)
• 4 Directly issued capital subject to phase out from CET1 (only applicable to mutually-owned companies)
• 5 Ordinary share capital issued by subsidiaries and held by third parties (amount allowed in group CET1)
• 6 Common Equity Tier 1 capital before regulatory adjustments
• Common Equity Tier 1 capital : regulatory adjustments
• 7 Prudential valuation adjustments
• 8 Goodwill (net of related tax liability)
• 9 Other intangibles other than mortgage servicing rights (net of related tax liability)
• 10 Deferred tax assets that rely on future profitability excluding those arising from temporary differences (net of related tax liability)
• 11 Cash-flow hedge reserve
• 12 Shortfall of provisions to expected losses
• 13 Securitisation gain on sale (as set out in paragraph 562 of Basel II framework)
• 14 Gains and losses due to changes in own credit risk on fair valued liabilities
• 15 Defined benefit superannuation fund net assets
• 16 Investments in own shares (if not already netted off paid-in capital on reported balance sheet)
• 17 Reciprocal cross-holdings in common equity
• 18 Investments in the capital of banking, financial and insurance entities that are outside the scope of regulatory consolidation, net of eligible short positions, where the ADI does not own more than 10% of the issued share capital (amount above 10% threshold)
• 19 Significant investments in the ordinary shares of banking, financial and insurance entities that are outside the scope of regulatory consolidation, net of eligible short positions (amount above 10% threshold)
• 20 Mortgage service rights (amount above 10% threshold)
• 21 Deferred tax assets arising from temporary differences (amount above 10% threshold, net of related tax liability)
• 22 Amount exceeding the 15% threshold
• 23 of which: significant investments in the ordinary shares of financial entities
• 24 of which: mortgage servicing rights
• 25 of which: deferred tax assets arising from temporary differences
• 26 National specific regulatory adjustments (sum of rows 26a, 26b, 26c, 26d, 26e, 26f, 26g, 26h, 26i and 26j)
• 26a of which: treasury shares
• 26b of which: offset to dividends declared under a dividend reinvestment plan (DRP), to the extent that the dividends are used to purchase new ordinary shares issued by the ADI
• 26c of which: deferred fee income
• 26d of which: equity investments in financial institutions not reported in rows 18, 19 and 23
• 26e of which: deferred tax assets not reported in rows 10, 21 and 25
• 26f of which: capitalised expenses
• 26g of which: investments in commercial (non-financial) entities that are deducted under APRA prudential requirements
• 26h of which: covered bonds in excess of asset cover in pools
• 26i of which: undercapitalisation of a non-consolidated subsidiary
• 26j of which: other national specific regulatory adjustments not reported in rows 26a to 26i
• 27 Regulatory adjustments applied to Common Equity Tier 1 due to insufficient Additional Tier 1 and Tier 2 to cover deductions
• 28 Total regulatory adjustments to Common Equity Tier 1
• 29 Common Equity Tier 1 Capital (CET1)
• Additional Tier 1 Capital: instruments
• 30 Directly issued qualifying Additional Tier 1 instruments
• 31 of which: classified as equity under applicable accounting standards
• 32 of which: classified as liabilities under applicable accounting standards
• 33 Directly issued capital instruments subject to phase out from Additional Tier 1
• 34 Additional Tier 1 instruments (and CET1 instruments not included in row 5) issued by subsidiaries and held by third parties (amount allowed in group AT1)
• 35 of which: instruments issued by subsidiaries subject to phase out
• 36 Additional Tier 1 Capital before regulatory adjustments
• Additional Tier 1 Capital: regulatory adjustments
• 37 Investments in own Additional Tier 1 instruments
• 38 Reciprocal cross-holdings in Additional Tier 1 instruments
• 39 Investments in the capital of banking, financial and insurance entities that are outside the scope of regulatory consolidation, net of eligible short positions, where the ADI does not own more than 10% of the issued share capital (amount above 10% threshold)
• 40 Significant investments in the capital of banking, financial and insurance entities that are outside the scope of regulatory consolidation (net of eligible short positions)
• 41 National specific regulatory adjustments (sum of rows 41a, 41b and 41c) -
• 41a of which: holdings of capital instruments in group members by other group members on behalf of third parties
• 41b of which: investments in the capital of financial institutions that are outside the scope of regulatory consolidations not reported in rows 39 and 40
• 41c of which: other national specific regulatory adjustments not reported in rows 41a and 41b
• 42 Regulatory adjustments applied to Additional Tier 1 due to insufficient Tier 2 to cover deductions
• 43 Total regulatory adjustments to Additional Tier 1 capital
• 44 Additional Tier 1 capital (AT1)
• 45 Tier 1 Capital (T1=CET1+AT1)
• Tier 2 Capital: instruments and provisions
• 46 Directly issued qualifying Tier 2 instruments
• 47 Directly issued capital instruments subject to phase out from Tier 2
• 48 Tier 2 instruments (and CET1 and AT1 instruments not included in rows 5 or 34) issued by subsidiaries and held by third parties (amount allowed in group T2)
• 49 of which: instruments issued by subsidiaries subject to phase out
• 50 Provisions
• 51 Tier 2 Capital before regulatory adjustments
• Tier 2 Capital: regulatory adjustments
• 52 Investments in own Tier 2 instruments
• 53 Reciprocal cross-holdings in Tier 2 instruments
• 54 Investments in the Tier 2 capital of banking, financial and insurance entities that are outside the scope of regulatory consolidation, net of eligible short positions, where the ADI does not own more than 10% of the issued share capital (amount above 10% threshold)
• 55 Significant investments in the Tier 2 capital of banking, financial and insurance entities that are outside the scope of regulatory consolidation, net of eligible short positions
• 56 National specific regulatory adjustments(sum of rows 56a, 56b and 56c)
• 56a of which: holdings of capital instruments in group members by other group members on behalf of third parties
• 56b of which: investments in the capital of financial institutions that are outside the scope of regulatory consolidation not reported in rows 54 and 55
• 56c of which: other national specific regulatory adjustments not reported in rows 56a and 56b
• 57 Total regulatory adjustments to Tier 2 capital
• 58 Tier 2 capital (T2)
• 59 Total capital (TC=T1+T2)
• 60 Total risk-weighted assets based on APRA standards
• Capital ratios and buffers
• 61 Common Equity Tier 1 (as a percentage of risk-weighted assets)
• 62 Tier 1 (as a percentage of risk-weighted assets)
• 63 Total capital (as a percentage of risk-weighted assets)
• 64 Buffer requirement (minimum CET1 requirement of 4.5% plus capital conservation buffer of 2.5% plus any countercyclical buffer requirements expressed as a percentage of risk-weighted assets)
• 65 of which: capital conservation buffer requirement
• 66 of which: ADI-specific countercyclical buffer requirements
• 67 of which: G-SIB buffer requirement (not applicable)
• 68 Common Equity Tier 1 available to meet buffers (as a percentage of risk-weighted assets)
• National minima (if different from Basel III)
• 69 National Common Equity Tier 1 minimum ratio (if different from Basel III minimum)
• 70 National Tier 1 minimum ratio (if different from Basel III minimum)
• 71 National total capital minimum ratio (if different from Basel III minimum)
• Amount below thresholds for deductions (not risk-weighted)
• 72 Non-significant investments in the capital of other financial entities
• 73 Significant investments in the ordinary shares of financial entities
• 74 Mortgage servicing rights (net of related tax liability)
• 75 Deferred tax assets arising from temporary differences (net of related tax liability)
• Applicable caps on the inclusion of provisions in Tier 2
• 76 Provisions eligible for inclusion in Tier 2 in respect of exposures subject to standardised approach (prior to application of cap)
• 77 Cap on inclusion of provisions in Tier 2 under standardised approach
• 78 Provisions eligible for inclusion in Tier 2 in respect of exposures subject to internal ratings-based approach (prior to application of cap)
• 79 Cap for inclusion of provisions in Tier 2 under internal ratings-based approach
• Capital instruments subject to phase-out arrangements (only applicable between 1 Jan 2018 and 1 Jan 2022)
• 80 Current cap on CET1 instruments subject to phase out arrangements
• 81 Amount excluded from CET1 due to cap (excess over cap after redemptions and maturities
• 82 Current cap on AT1 instruments subject to phase out arrangements
• 83 Amount excluded from AT1 instruments due to cap (excess over cap after redemptions and maturities)
• 84 Current cap on T2 instruments subject to phase out arrangements
• 85 Amount excluded from T2 due to cap (excess over cap after redemptions and maturities)

 

2.             An ADI must also disclose the geographic breakdown, at country level, of its private sector credit exposures when disclosing its countercyclical capital buffer requirement.

Guidelines for the capital disclosure template

 

3.             In completing Table 1, an ADI must have regard to the following Table 1A, which sets out an explanation of each row of Table 1. An ADI must report deductions from capital as positive numbers and additions to capital as negative numbers. For example, goodwill (refer to row 8) must be reported as a positive number, as must gains due to the change in the own credit risk of the bank (refer to row 14). However, losses due to the change in the own credit risk of the ADI must be reported as a negative number as these are added back in the calculation of Common Equity Tier 1 Capital.

Table 1A: Explanation of each row of the capital disclosure template

 

• Explanation of each row of the capital disclosure template
• Row number Explanation
• 1 Instruments issued by the parent company of the reporting group that meet all of the CET1 entry criteria set out in paragraph 53 of Basel III. This must be equal to the sum of ordinary shares and other instruments for mutually-owned ADIs, both of which must meet the ordinary share criteria. This must be net of treasury shares and other investments in own shares to the extent that these are already derecognised on the balance sheet under the relevant accounting standards. Other paid-in capital elements must be excluded. All minority interest must be excluded.
• 2 Retained earnings, prior to all regulatory adjustments. In accordance with paragraph 52 of Basel III, this row must include interim profit and loss that has met any audit, verification or review procedures that the supervisory authority has put in place. Dividends are to be deducted when declared in accordance with Australian Accounting Standards.
• 3 Accumulated other comprehensive income and other disclosed reserves, prior to all regulatory adjustments.
• 4 Directly issued capital subject to phase-out from CET1 in accordance with the requirements of paragraph 95 of Basel III. This is only applicable to mutually-owned ADIs. All other ADIs must report zero in this row.
• 5 Ordinary share capital issued by subsidiaries and held by third parties. Only the amount that is eligible for inclusion in group CET1 must be reported here, as determined by the application of paragraph 62 of Basel III (see Annex 3 of Basel III for example calculation).
• 6 Sum of rows 1 to 5.
• 7 Prudential valuation adjustments according to the requirements of paragraphs 698 to 701 of Basel II framework, taking into account the guidance set out in Supervisory guidance for assessing banks’ financial instrument fair value practices, April 2009 (in particular, Principle 10)
• 8 Goodwill net of related tax liability, as set out in paragraphs 67 to 68 of Basel III.
• 9 Other intangibles other than mortgage servicing rights (net of related tax liability), as set out in paragraph 67 to 68 of Basel III.
• 10 Deferred tax assets that rely on future profitability excluding those arising from temporary differences (net of related tax liability), as set out in paragraph 69 of Basel III.
• 11 The element of the cash-flow hedge reserve described in paragraphs 71 and 72 of Basel III.
• 12 Shortfall of provisions to expected losses as described in paragraph 73 of Basel III.
• 13 Securitisation gain on sale (as set out in paragraph 562 of Basel II framework)
• 14 Gains and losses due to changes in own credit risk on fair valued liabilities, as set out in paragraph 75 of Basel III.
• 15 Defined benefit pension fund net assets as set out in paragraphs 76 and 77 of Basel III.
• 16 Investments in own shares (if not already netted off paid-in capital on reported balance sheet), as set out in paragraph 78 of Basel III.
• 17 Reciprocal cross-holdings in common equity as set out in paragraph 79 of Basel III.
• 18 Investments in the capital of banking, financial and insurance entities that are outside the scope of regulatory consolidation, net of eligible short positions, where the ADI does not own more than 10% of the issued share capital (amount above 10% threshold), amount to be deducted from CET1 in accordance with paragraphs 80 to 83 of Basel III.
• 19 Significant investments in the ordinary shares of banking, financial and insurance entities that are outside the scope of regulatory consolidation, net of eligible short positions (amount above 10% threshold), amount to be deducted from CET1 in accordance with paragraphs 84 to 88 of Basel III.
• 20 Mortgage servicing rights (amount above 10% threshold), amount to be deducted from CET1 in accordance with paragraphs 87 and 88 of Basel III.
• 21 Deferred tax assets arising from temporary differences (amount above 10% threshold, net of related tax liability), amount to be deducted from CET1 in accordance with paragraphs 87 and 88 of Basel III.
• 22 Total amount by which the 3 threshold items exceed the 15% threshold, excluding amounts reported in rows 19 to 21, calculated in accordance with paragraphs 87 and 88 of Basel III.
• 23 The amount reported in row 22 that relates to significant investments in the ordinary shares of financial entities.
• 24 The amount reported in row 22 that relates to mortgage servicing rights.
• 25 The amount reported in row 22 that relates to deferred tax assets arising from temporary differences.
• 26 Any national specific regulatory adjustments that national authorities required to be applied to CET1 in addition to the Basel III minimum set of adjustments. (This will be the sum of rows 26a, 26b, 26c, 26d, 26e, 26f, 26g, 26h, 26i and 26j).
• 26a Treasury shares if not included in share capital calculated under Basel III (refer to Prudential Standard APS 111 Capital Adequacy: Measurement of Capital (APS 111), paragraphs 39 to 41).
• 26b Offset to dividends declared due to a dividend reinvestment plan (DRP), to the extent that the dividends are used to purchase new ordinary shares issued by the ADI (APS 111, paragraph 21).
• 26c Deferred fee income (APS 111, paragraphs 22 and 23).
• 26d Capital impact of equity investments in financial institutions not reported in rows 18, 19 and row 23 (APS 111, Attachment D paragraphs 8 to 14).
• 26e Capital impact of deferred tax assets (net of related deferred tax liability) not reported in rows 10, 21 and 25.
• 26f Capitalised expenses (APS 111, Attachment D paragraph 27b).
• 26g Investments in commercial (non-financial) entities deducted under APRA standards (APS 111, Attachment D paragraph 25).
• 26h Covered bonds in excess of asset cover in pools (APS 111, Attachment D paragraph 21).
• 26i Undercapitalisation of a non-consolidated subsidiary (APS 111 Attachment D paragraph 37).
• 26j Any other national discretion items impacting CET1 (e.g. mortgage servicing rights) not reported in rows 26a to 26i.
• 27 Regulatory adjustments applied to Common Equity Tier 1 due to insufficient Additional Tier 1 and Tier 2 to cover deductions. If the amount reported in row 43 exceeds the amount reported in row 36 the excess is to be reported here.
• 28 Total regulatory adjustments to Common Equity Tier 1, to be calculated as the sum of rows 7 to 22 plus rows 26 and 27.
• 29 Common Equity Tier 1 capital (CET1), to be calculated as row 6 minus row 28.
• 30 Instruments issued by the parent company of the reporting group that meet all of the AT1 entry criteria set out in paragraph 55 of Basel III. All instruments issued by subsidiaries of the consolidated group must be excluded from this row. This row may include Additional Tier 1 capital issued by a special purpose vehicle (SPV) of the parent company only if it meets the requirements set out in paragraph 65 of Basel III.
• 31 The amount in row 30 classified as equity under Australian Accounting Standards.
• 32 The amount in row 30 classified as liabilities under Australian Accounting Standards.
• 33 Directly issued capital instruments subject to phase out from Additional Tier 1 in accordance with the requirements of paragraph 94(g) of Basel III.
• 34 Additional Tier 1 instruments (and CET1 instruments not included in row 5) issued by subsidiaries and held by third parties, the amount allowed in group AT1 in accordance with paragraph 63 of Basel III (see Annex 3 of Basel III for example calculation).
• 35 The amount reported in row 34 that relates to instruments issued by subsidiaries subject to phase out from AT1 in accordance with the requirements of paragraph 94(g) of Basel III.
• 36 The sum of rows 30, 33 and 34.
• 37 Investments on own Additional Tier 1 instruments, amount to be deducted from AT1 in accordance with paragraph 78 of Basel III.
• 38 Reciprocal cross-holdings in Additional Tier 1 instruments, amount to be deducted from AT1 in accordance with paragraph 79 of Basel III.
• 39 Investments in the capital of banking, financial and insurance entities that are outside the scope of regulatory consolidation where the ADI does not own more than 10% of the issued ordinary share capital of the entity (net of eligible short positions), amount to be deducted from AT1 in accordance with paragraphs 80 to 83 of Basel III.
• 40 Significant investments in the capital of banking, financial and insurance entities that are outside the scope of regulatory consolidation, (net of eligible short positions), amount to be deducted from AT1 in accordance with paragraphs 84 and 85 of Basel III.
• 41 National specific regulatory adjustments that national authorities require to be applied to T1 in addition to the Basel III minimum set of adjustments. (This will be the sum of rows 41a, 41b and 41c).
• 41a Holdings of capital instruments in group members by other group members on behalf of third parties (APS 111, paragraphs 39 to 41).
• 41b Investments in Additional Tier 1 instruments of financial institutions that are outside the scope of regulatory consolidation not reported in rows 39 and 40 (APS 111, Attachment D paragraphs 8 to 14).
• 41c Any other national discretion items impacting on AT1 not reported in rows 41a or 41b.
• 42 Regulatory adjustments applied to Additional Tier 1 due to insufficient Tier 2 to cover deductions. If the amount reported in row 57 exceeds the amount reported in row 51 the excess is to be reported here.
• 43 The sum of rows 37 to 42.
• 44 Additional Tier 1 capital, to be calculated as row 36 minus row 43.
• 45 Tier 1 capital, to be calculated as row 29 plus row 44.
• 46 Instruments issued by the parent company of the reporting group that meet all of the Tier 2 entry criteria set out in paragraph 58 of Basel III and any related share surplus as set out in paragraph 59 of Basel III. All instruments issued by subsidiaries of the consolidated group must be excluded from this row. This row may include Tier 2 capital issued by an SPV of the parent company only if it meets the requirements set out in paragraph 65 of Basel III.
• 47 Directly issued capital instruments subject to phase out from Tier 2 in accordance with the requirements of paragraph 94(g) of Basel III.
• 48 Tier 2 instruments (and CET1 and AT1 instruments not included in rows 5 or 32) issued by subsidiaries and held by third parties (amount allowed in group Tier 2), in accordance with paragraph 64 of Basel III.
• 49 The amount reported in row 48 that relates to instruments subject to phase out from Tier 2 in accordance with the requirements of paragraph 94(g) of Basel III.
• 50 Provisions included in Tier 2 instruments, calculated in accordance with paragraphs 60 and 61 of Basel III.
• 51 The sum of rows 46 to 48 and row 50.
• 52 Investments in own Tier 2 instruments, amount to be deducted from Tier 2 in accordance with paragraph 78 of Basel III.
• 53 Reciprocal cross-holdings in Tier 2 instruments, amount to be deducted from Tier 2 in accordance with paragraph 79 of Basel III.
• 54 Investments in the capital of banking, financial and insurance entities that are outside the scope of regulatory consolidation where the ADI does not own more than 10% of the issued ordinary share capital of the entity (net of eligible short positions), amount to be deducted from Tier 2 in accordance with paragraphs 80 to 83 of Basel III.
• 55 Significant investments in the capital of banking, financial and insurance entities that are outside the scope of regulatory consolidation (net of eligible short positions), amount to be deducted from Tier 2 in accordance with paragraphs 84 and 85 of Basel III.
• 56 Any national specific regulatory adjustments that national authorities require to be applied to Tier 2 in addition to the Basel III minimum set of adjustments. (This will be the sum of rows 56a, 56b and 56c).
• 56a Holdings of capital instruments in group members by other group members on behalf of third parties (APS 111, paragraphs 39 to 41).
• 56b Investments in Tier 2 instruments of financial institutions that are outside the scope of regulatory consolidation not reported in rows 54 and 55 (APS 111, Attachment D paragraphs 8 to 14).
• 56c Any other national discretion items impacting on T2, not reported in row 56a or 56b.
• 57 The sum of rows 52 to 56.
• 58 Tier 2 capital, to be calculated as row 51 minus row 57.
• 59 Total capital, to be calculated as row 45 plus row 58.
• 60 Total risk-weighted assets of the reporting group based on APRA’s prudential standards.
• 61 Common Equity Tier 1 ratio (as a percentage of risk-weighted assets), to be calculated as row 29 divided by row 60 (expressed as a percentage). This must be the same as reported to APRA in accordance with Reporting Standard ARS 110.0 Capital Adequacy (ARS 110.0).
• 62 Tier 1 ratio (as a percentage of risk-weighted assets), to be calculated as row 45 divided by row 60 (expressed as a percentage). This must be the same as reported to APRA in accordance with ARS 110.0.
• 63 Total capital ratio (as a percentage of risk-weighted assets), to be calculated as row 59 divided by row 60 (expressed as a percentage). This must be the same as reported to APRA in accordance with ARS 110.0.
• 64 Buffer requirements (minimum CET1 requirement plus capital conservation buffer plus countercyclical buffer requirements expressed as a percentage of risk-weighted assets). To be calculated as 4.5% plus 2.5% plus the ADI-specific countercyclical buffer requirement calculated in accordance with paragraphs 142 to 145 of Basel III and based on the latest relevant jurisdictional countercyclical buffers available.
• 65 The amount in row 64 (expressed as a percentage of risk-weighted assets) that relates to the capital conservation buffer requirement, i.e. ADIs are to report 2.5% here.
• 66 The amount in row 64 (expressed as a percentage of risk-weighted assets) that relates to any ADI-specific countercyclical buffer requirement.
• 67 The amount in row 64 (expressed as a percentage of risk-weighted assets) that relates to the ADI’s G-SIB buffer requirement (not applicable).
• 68 Common Equity Tier 1 available to meet buffers (as a percentage of risk-weighted assets). To be calculated as the CET1 ratio of the ADI, less any common equity used to meet the ADI’s Tier 1 and Total Capital requirements.
• 69 This field is blank because APRA has not departed from the Basel III minimum CET1 requirement of 4.5%.
• 70 This field is blank because APRA has not departed from the Basel III minimum T1 requirement of 6.0%.
• 71 This field is blank because APRA has not departed from the Basel III minimum Total Capital requirement of 8.0%.
• 72 Non-significant investments in the capital of other financials, the total amount of such holdings that are not reported in rows 18, 39 and 54.
• 73 Significant investments in the common stock of financials, the total amount of such holdings that are not reported in rows 19 and 23.
• 74 Mortgage servicing rights the total amount of such holdings that are not reported in rows 20 and 24.
• 75 Deferred tax assets arising from temporary differences (net of related tax liability), the total amount of such holdings that are not reported in rows 21 and 25.
• 76 Provisions eligible for inclusion in Tier 2 in respect of exposures subject to standardised approach, calculated in accordance with paragraph 60 of Basel III, prior to the application of the cap.
• 77 Cap on inclusion of provisions in Tier 2 under standardised approach, calculated in accordance with paragraph 60 of Basel III.
• 78 Provisions eligible for inclusion in Tier 2 in respect of exposures subject to internal ratings-based approach, calculated in accordance with paragraph 61 of Basel III, prior to the application of the cap.
• 79 Cap for inclusion of provisions in Tier 2 under internal ratings-based approach, calculated in accordance with paragraph 61 of Basel III.
• 80 Current cap on CET1 instruments subject to phase out arrangements, see paragraph 95 of Basel III.
• 81 Amount excluded from CET1 due to cap (excess over cap after redemptions and maturities), see paragraph 95 of Basel III.
• 82 Current cap on AT1 instruments subject to phase out arrangements, see paragraph 94(g) of Basel III.
• 83 Amount excluded from AT1 instruments due to cap (excess over cap after redemptions and maturities), see paragraph 94(g) of Basel III.
• 84 Current cap on T2 instruments subject to phase out arrangements, see paragraph 94(g) of Basel III.
• 85 Amount excluded from T2 due to cap (excess over cap after redemptions and maturities), see paragraph 94(g) of Basel III.

 

 

Attachment B

Main features of capital instruments

1. An ADI must disclose the information in Table 2 for each capital instrument included in its Regulatory Capital.

Table 2: Main features template

• Disclosure template for main features of Regulatory Capital instruments
• 1 Issuer
• 2 Unique identifier (eg CUSIP, ISIN or Bloomberg identifier for private placement)
• 3 Governing law(s) of the instrument
• Regulatory treatment
• 4 Transitional Basel III rules
• 5 Post-transitional Basel III rules
• 6 Eligible at solo/group/group & solo
• 7 Instrument type (ordinary shares/preference shares/subordinated notes/other)
• 8 Amount recognised in Regulatory Capital (Currency in mil, as of most recent reporting date)
• 9 Par value of instrument
• 10 Accounting classification
• 11 Original date of issuance
• 12 Perpetual or dated
• 13 Original maturity date
• 14 Issuer call subject to prior supervisory approval
• 15 Optional call date, contingent call dates and redemption amount
• 16 Subsequent call dates, if applicable
• Coupons/dividends
• 17 Fixed or floating dividend/coupon
• 18 Coupon rate and any related index
• 19 Existence of a dividend stopper
• 20 Fully discretionary, partially discretionary or mandatory
• 21 Existence of step up or other incentive to redeem
• 22 Noncumulative or cumulative
• 23 Convertible or non-convertible
• 24 If convertible, conversion trigger (s)
• 25 If convertible, fully or partially
• 26 If convertible, conversion rate
• 27 If convertible, mandatory or optional conversion
• 28 If convertible, specify instrument type convertible into
• 29 If convertible, specify issuer of instrument it converts into
• 30 Write-down feature
• 31 If write-down, write-down trigger(s)
• 32 If write-down, full or partial
• 33 If write-down, permanent or temporary
• 34 If temporary write-down, description of write-up mechanism
• 35 Position in subordination hierarchy in liquidation (specify instrument type immediately senior to instrument)
• 36 Non-compliant transitioned features
• 37 If yes, specify non-compliant features

 

Guidance on main features template

 

2.             In completing the main features template, an ADI must have regard to the explanation of each item set out in the following Table 2A.

Table 2A: Further explanation of items in main features disclosure template

 

• Further explanation of items in main features disclosure template
• 1 Identifies issuer legal entity. Free text
• 2 Unique identifier (eg CUSIP, ISIN or Bloomberg identifier for private placement) Free text
• 3 Specifies the governing law(s) of the instrument Free text
• 4 Specifies the Regulatory Capital treatment during the Basel III transitional Basel III phase (i.e. the component of capital that the instrument is being phased-out from). Select from menu: [Common Equity Tier 1] [Additional Tier 1] [Tier 2]
• 5 Specifies Regulatory Capital treatment under Basel III rules not taking into account transitional treatment. Select from menu: [Common Equity Tier 1] [Additional Tier 1] [Tier 2] [Ineligible]
• 6 Specifies the level(s) within the group at which the instrument is included in capital. Select from menu: [Solo] [Group] [Solo and Group]
• 7 Specifies instrument type, varying by jurisdiction. Helps provide more granular understanding of features, particularly during transition. Select from menu: [Ordinary shares] [Preference shares] [Subordinated notes] [Other]
• 8 Specifies amount recognised in Regulatory Capital. Free text
• 9 Par value of instrument Free text
• 10 Specifies accounting classification. Helps to assess loss absorbency. Select from menu: [Shareholders’ equity] [Liability – amortised cost] [Liability – fair value option] [Non-controlling interest in consolidated subsidiary]
• 11 Specifies date of issuance. Free text
• 12 Specifies whether dated or perpetual. Select from menu: [Perpetual] [Dated]
• 13 For dated instrument, specifies original maturity date (day, month and year). For perpetual instrument put “no maturity”. Free text
• 14 Specifies whether there is an issuer call option. Helps to assess permanence. Select from menu: [Yes] [No]
• 15 For instrument with issuer call option, specifies first date of call if the instrument has a call option on a specific date (day, month and year) and, in addition, specifies if the instrument has a tax and/or regulatory event call. Also specifies the redemption price. Helps to assess permanence. Free text
• 16 Specifies the existence and frequency of subsequent call dates, if applicable. Helps to assess permanence. Free text
• 17 Specifies whether the coupon/dividend is fixed over the life of the instrument, floating over the life of the instrument, currently fixed but will move to a floating rate in the future, currently floating but will move to a fixed rate in the future. Select from menu: [Fixed], [Floating] [Fixed to floating], [Floating to fixed]
• 18 Specifies the coupon rate of the instrument and any related index that the coupon/dividend rate references. Free text
• 19 Specifies whether the non payment of a coupon or dividend on the instrument prohibits the payment of dividends on common shares (ie whether there is a dividend stopper). Select from menu: [yes], [no]
• 20 Specifies whether the issuer has full discretion, partial discretion or no discretion over whether a coupon/dividend is paid. If the ADI has full discretion to cancel coupon/dividend payments under all circumstances it must select “fully discretionary” (including when there is a dividend stopper that does not have the effect of preventing the ADI from cancelling payments on the instrument). If there are conditions that must be met before payment can be cancelled (e.g. capital below a certain threshold), the ADI must select “partially discretionary”. If the ADI is unable to cancel the payment outside of insolvency the ADI must select “mandatory”. Select from menu: [Fully discretionary] [Partially discretionary] [Mandatory]
• 21 Specifies whether there is a step-up or other incentive to redeem. Select from menu: [Yes] [No]
• 22 Specifies whether dividends / coupons are cumulative or noncumulative. Select from menu: [Noncumulative] [Cumulative]
• 23 Specifies whether instrument is convertible or not. Helps to assess loss absorbency. Select from menu: [Convertible] [Nonconvertible]
• 24 Specifies the conditions under which the instrument will convert, including point of non-viability. Where one or more authorities have the ability to trigger conversion, the authorities must be listed. For each of the authorities it must be stated whether it is the terms of the contract of the instrument that provide the legal basis for the authority to trigger conversion (a contractual approach) or whether the legal basis is provided by statutory means (a statutory approach). Free text
• 25 For conversion trigger separately, specifies whether the instrument will: (i) always convert fully; (ii) may convert fully or partially; or (iii) will always convert partially Free text referencing one of the options above
• 26 Specifies rate of conversion into the more loss absorbent instrument. Helps to assess the degree of loss absorbency. Free text
• 27 If convertible, specifies whether conversion is mandatory or optional. Helps to assess loss absorbency. Select from menu: [Mandatory] [Optional] [NA]
• 28 If convertible, specifies the instrument type into which it can be converted. Helps to assess loss absorbency. Select from menu: [Common Equity Tier 1] [Additional Tier 1] [Tier 2] [Other]
• 29 If convertible, specifies the issuer of the instrument into which it can be converted. Free text
• 30 Specifies whether there is a write down feature. Helps to assess loss absorbency. Select from menu: [Yes] [No]
• 31 Specifies the trigger at which write-down occurs, including point of non-viability. Where one or more authorities have the ability to trigger write-down, the authorities must be listed. For each of the authorities it must be stated whether it is the terms of the contract of the instrument that provide the legal basis for the authority to trigger write-down (a contractual approach) or whether the legal basis is provided by statutory means (a statutory approach). Free text
• 32 For each write-down trigger separately, specifies whether the instrument will: (i) always be written down fully: (ii) may be written down partially; or (iii) will always be written down partially. Helps assess the level of loss absorbency at write-down. Free text referencing one of the options above
• 33 For write down instrument, specifies whether write down is permanent or temporary. Helps to assess loss absorbency. Select from menu: [Permanent] [Temporary] [NA]
• 34 For instrument that has a temporary write-down, description of write-up mechanism. Free text
• 35 Specifies instrument to which it is most immediately subordinate. Helps to assess loss absorbency on gone-concern basis. Where applicable, ADIs must specify the column numbers of the instruments in the completed main features template to which the instrument is most immediately subordinate. Free text
• 36 Specifies whether there are non-compliant features. Select from menu: [Yes] [No]
• 37 Specifies any non-compliant features. Helps to assess instrument loss absorbency. Free text

Attachment C

Risk exposures and assessment (all ADIs)

1. A locally incorporated ADI must make the disclosures required in this Attachment to the extent applicable to that ADI.

Table 3:  Capital adequacy

Table 4: Credit risk[15]  

Table 5: Securitisation exposures[19]

.

 

Attachment D

Risk exposure and assessment (ADIs with IRB and AMA approval)

1. The disclosures in this Attachment are only required to be made by an ADI with approval to use the IRB and AMA approaches to credit and operational risk, respectively. While an ADI may augment the required information with additional material (including graphics, etc), its disclosures must conform to the basic order/layout as follows.

Capital

2.             An ADI must disclose the items set out in Table 6 to the extent applicable.

Table 6: Capital adequacy

General qualitative disclosure requirement

3.             For each separate risk area (e.g. credit, market, operational, interest rate risk in the banking book, equity) an ADI must describe its risk management objectives and policies, including:

(a)          strategies and processes;

(b)          the structure and organisation of the relevant risk management function;

(c)          the scope and nature of risk reporting and/or measurement systems; and

(d)          policies for hedging and/or mitigating risk and strategies and processes for monitoring the continuing effectiveness of hedges/mitigants.

Credit risk

4.             An ADI must disclose the items set out in Tables 7 to 11 to the extent applicable.

Table 7: Credit risk - general disclosures[21]

• Qualitative disclosures (a) The general qualitative disclosure requirement (refer to paragraph 3 of this Attachment) with respect to credit risk, including:• definitions of past due and impaired (for regulatory purposes);• description of approaches followed for creation of specific provisions and general reserve for credit losses;• discussion of the ADI’s credit risk management policy; and• for ADIs that have partly, but not fully adopted either the foundation IRB or the advanced IRB approach, a description of the nature of exposures within each portfolio that are subject to the (i) standardised; (ii) foundation IRB; and (iii) advanced IRB approaches and of management’s plans and timing for migrating exposures to full implementation of the applicable approach.
• (
• Quantitative disclosures (b) Total gross credit risk exposures, plus average gross exposure over the period broken down by major types of credit exposure[22] and, separately, by portfolio.
• (c) Geographic distribution[23] of exposures, broken down in significant areas by major types of credit exposure.
• (d) Industry or counterparty type distribution of exposures, broken down by major types of credit exposure.
• (e) Residual contractual maturity breakdown of the whole portfolio, broken down by major types of credit exposure.
• (f) By major industry or counterparty type and, separately, by portfolio:• amount of impaired facilities and, if available, past due facilities provided separately[24];• specific provisions; and• charges for specific provisions and write-offs during the period.
• (g) Amount of impaired facilities and, if available, past due facilities provided separately broken down by significant geographic areas including, if practical, the amounts of specific provisions and general reserve for credit losses related to each geographical area; the portion of general reserve not allocated to a geographical area must be disclosed separately.
• (h) Reconciliation of changes in the provisions/reserves for credit impairment[25].
• (i) For each portfolio, the amount of exposures (for IRB ADIs, drawn plus exposure at default (EAD) on undrawn) subject to the: (i) standardised; (ii) foundation IRB; and (iii) advanced IRB approaches.
• (j) The general reserve for credit losses.

Table 8: Credit risk - disclosures for portfolios subject to the standardised approach and supervisory risk-weights in the IRB approaches

Table 9: Credit risk - disclosures for portfolios subject to IRB approaches[27]

• Qualitative disclosures (a) APRA’s acceptance of approach/approved transition.
• (b) Explanation and review of the:• structure of internal rating systems and relation between internal and external ratings;• use of internal estimates other than for IRB capital purposes;• process for managing and recognising credit risk mitigation; and• control mechanisms for the rating system including discussion of independence, accountability, and rating systems review.
• (c) Description of the internal ratings process, provided separately for distinct portfolios:• corporate (including small and medium-sized entities (SMEs), SL and purchased corporate receivables); • sovereign and bank;• residential mortgages;• qualifying revolving retail[28]; and• other retail.The description must include, for each portfolio:• the types of exposure included in the portfolio;• the definitions, methods and data for estimation and validation of probability of default (PD), and (for portfolios subject to the advanced IRB approach) loss given default (LGD) and/or EAD, including assumptions employed in the derivation of these variables[29]; and• the permitted material deviations from the reference definition of default, including the broad segments of the portfolio(s) affected by such deviations.
• Quantitative disclosures: risk assessment (d) For each portfolio (as defined above) except residential mortgages, qualifying revolving retail and other retail, present the following information across a sufficient number of PD grades (including default) to allow for a meaningful differentiation of credit risk[30]:• total exposures (for corporate, sovereign and bank, outstanding loans and EAD on undrawn commitments)[31];• for ADIs on the advanced IRB approach, exposure-weighted average LGD (percentage); and• exposure-weighted average risk-weight.For an ADI on the advanced IRB approach, the amount of undrawn commitments and exposure-weighted average EAD for each portfolio[32].For each retail portfolio (as defined above), either[33]: • disclosures as outlined above on a pool basis (i.e. same as for non-retail portfolios); or• analysis of exposures on a pool basis (outstanding loans and EAD on commitments) against a sufficient number of expected loss (EL) grades to allow for a meaningful differentiation of credit risk.
• Quantitative disclosures: historical results (e) Actual losses (e.g. write-offs and specific provisions) in the preceding period for each portfolio (as defined above) and how this differs from past experience. A discussion of the factors that impacted on the loss experience in the preceding period. For example, has the ADI experienced higher than average default rates, or higher than average LGDs and EADs?
• (f) The ADIs’ estimates against actual outcomes over a longer period[34]. At a minimum, this must include information on estimates of losses against actual losses in each portfolio (as defined above) over a period sufficient to allow for a meaningful assessment of the performance of the internal rating processes for each portfolio[35]. Where appropriate, an ADI must further decompose this to provide analysis of PDs and, for an ADI on the advanced IRB approach, LGD and EAD outcomes against estimates provided in the quantitative risk assessment disclosures above[36].

Table 10: Credit risk mitigation disclosures[37]  

 

Table 11: General disclosure for exposures related to counterparty credit risk

• Qualitative disclosures (a) The general qualitative disclosure requirement (refer to paragraph 3 of this Attachment) with respect to derivatives and counterparty credit risk (CCR), including discussion of the:• methodology used to assign economic capital and credit limits for CCR exposures;• policies for securing collateral and establishing credit reserves;• policies for wrong-way risk exposures; and• the impact of the amount of collateral the ADI would have to provide given a credit rating downgrade.
• Quantitative disclosures (b) Gross positive fair value of contracts, netting benefits, netted current credit exposure, collateral held (including type, e.g. cash, government securities, etc.), and net derivatives credit exposure[39]. Also report measures for exposure at default, or exposure amount, under the current exposure method.The notional value of credit derivative hedges, and the distribution of current credit exposure by types of credit exposure[40].
• (c) Credit derivative transactions that create exposures to CCR (notional value), segregated between use for the ADI’s own credit portfolio, as well as in its intermediation activities, including the distribution of the credit derivatives products used[41], broken down further by protection bought and sold within each product group.

Table 12: Securitisation exposures[42]

• Qualitative disclosures[43] (a) The general qualitative disclosure requirement (refer to paragraph 3 of this Attachment) with respect to all securitisation (including synthetics) transactions, whether an originating ADI or not in relation to a scheme, including a discussion of:• the ADI’s objectives in relation to securitisation activity, including the extent to which these activities transfer credit risk of the underlying securitised exposures away from the ADI to other entities and including the types of risks assumed and retained with resecuritisation activity[44];• the nature of other risks (e.g. liquidity risk) inherent in securitised assets; • the various roles played by the ADI in the securitisation process[45] and an indication of the extent of the ADI’s involvement in each of them;• a description of the processes in place to monitor changes in the credit and market risk of securitisation exposures[46] (for example, how the behaviour of the underlying assets impacts securitisation exposures) including how those processes differ for resecuritisation exposures;• a description of the ADI’s policy governing the use of credit risk mitigation to mitigate the risks retained through securitisation and resecuritisation exposures; and • the Regulatory Capital approaches that are applicable to the ADI’s securitisation activities.

• (b) A list of:

• the types of Special Purpose Vehicles (SPVs) that the ADI, as sponsor[47] uses to securitise third-party exposures. Indicate whether the ADI has exposure to these SPVs, either on- or off-balance sheet; and

• affiliated entities i) that the ADI manages or advises; and ii) that invest either in the securitisation exposures that the ADI has securitised or in SPVs that the ADI sponsors.

• (c) A summary of the ADI's accounting policies for securitisation activities, including:• whether the transactions are treated as sales or financings;• recognition of gain on sale;• methods and key assumptions (including inputs) applied in valuing positions retained or purchased[48];• changes in methods and key assumptions from the previous period and impact of the changes; • treatment of synthetic securitisations if this is not covered by other accounting policies (e.g. on derivatives);• how exposures intended to be securitised (e.g. in a pipeline or warehouse) are valued and whether they are recorded in the banking book or the trading book; and• policies for recognising liabilities on the balance sheet for arrangements that could require the ADI to provide financial support for securitised assets.

• (d) In the banking book, the names of ECAIs used for securitisations and the types of securitisation exposure for which each agency is used.

• (e) Description of the Internal Assessment Approach (IAA) process. The description must include:

• structure of the internal assessment process and relation between internal assessment and external ratings, including information on ECAIs as referenced in 10(d);

• use of internal assessment other than for IAA capital purposes;

• control mechanisms for the internal assessment process including discussion of independence, accountability, and internal assessment process review;

• the exposure type[49] to which the internal assessment process is applied; and

• stress factors used for determining credit enhancement levels, by exposure type.

• (f) An explanation of significant changes to any of the quantitative information (e.g. amounts of assets intended to be securitised, movement of assets between banking book and trading book) since the last reporting period.

• Quantitative disclosures: Banking book (g) The total amount of exposures securitised[50] by the ADI and (broken down into traditional/synthetic) by exposure type, separately for securitisations of third-party exposures for which the ADI acts only as sponsor.

• (h) For exposures securitised by the ADI[51]:• amount of impaired/past due assets securitised broken down by exposure type; and• losses recognised by the ADI during the current period broken down by exposure type[52].

• (i) The total amount of outstanding exposures intended to be securitised broken down by exposure type[53].

• (j) Summary of current period’s securitisation activity, including the total amount of exposures securitised (by exposure type) and recognised gain or loss on sale by exposure type

• (k) Aggregate amount of:

• on-balance sheet securitisation exposures[54] retained or purchased broken down by exposure type; and

• off-balance sheet securitisation exposures broken down by exposure type.

• (l) - Aggregate amount of securitisation exposures and the associated IRB capital charges, broken down between securitisation and resecuritisation exposures and further broken down into a meaningful number of risk-weight bands for the Regulatory Capital approach used;

• Exposures and credit enhancements that have been deducted entirely from CET1 must be disclosed separately by exposure type[55].

• (m) For securitisations subject to the early amortisation treatment, the following items by exposure type for securitised facilities:• the aggregate drawn exposures attributed to the seller’s and investors’ interests;• the aggregate IRB capital charges incurred by the ADI against its retained (i.e. the seller’s) shares of the drawn balances and undrawn lines; and• the aggregate IRB capital charges incurred by the ADI against the investors’ shares of drawn balances and undrawn lines.

• (n) Aggregate amount of resecuritisation exposures retained or purchased broken down according to:

• exposures to which credit risk mitigation is applied and those not applied; and

• exposures to guarantors broken down according to guarantor creditworthiness categories or guarantor name.

• Quantitative disclosures: Trading book (o) The total amount of outstanding exposures securitised by the ADI (broken down into traditional/synthetic) by exposure type, separately for securitisations of third-party exposures for which the bank acts only as sponsor.

• (p) The total amount of outstanding exposures intended to be securitised broken down by exposure type.

• (q) Summary of current period’s securitisation activity, including the total amount of exposures securitised (by exposure type) and recognised gain or loss on sale by exposure type.

• (r) Aggregate amount of exposures securitised by the ADI and subject to Prudential Standard APS 116 Capital Adequacy: Market Risk (APS 116) (standard method and IMA); (broken down into traditional/synthetic), by exposure type.

• (s) Aggregate amount of:

• on-balance sheet securitisation exposures retained or purchased broken down by exposure type; and

• off-balance sheet securitisation exposures broken down by exposure type.

• (t) Aggregate amount of securitisation exposures retained or purchased separately for:

• securitisation exposures retained or purchased subject to IMA for specific risk; and

• securitisation exposures subject to APS 120 for specific risk broken down into a meaningful number of risk weight bands for each Regulatory Capital approach.

• (u) Aggregate amount of:

• the capital requirements for these securitisation exposures subject to IMA broken down into appropriate risk classifications (e.g. default risk, migration risk and correlation risk);

• the capital requirements for the securitisation exposures (resecuritisation and securitisation), subject to APS 120 broken down into a meaningful number of risk weight bands for each Regulatory Capital approach; and

• securitisation exposures that are deducted entirely from Tier 1 Capital, credit enhancements deducted from Total Capital, and other exposures deducted from Total Capital must be disclosed separately by exposure type.

• (v) For securitisations subject to the early amortisation treatment, the following items by exposure type for securitised facilities:

• the aggregate drawn exposures attributed to the seller’s and investors’ interests;

• the aggregate IRB capital charges incurred by the ADI against its retained (i.e. the seller’s) shares of the drawn balances and undrawn lines; and

• the aggregate IRB capital charges incurred by the ADI against the investor’s shares of drawn balances and undrawn lines.

• (w) Aggregate amount of resecuritisation exposures retained or purchased broken down according to:

• exposures to which credit risk mitigation is applied and those not applied; and

• exposures to guarantors broken down according to guarantor credit worthiness categories or guarantor name.

Market risk disclosures

5.             An ADI must disclose the items set out in Table 13 and 14 to the extent applicable. 

Table 13: Market risk - disclosures for ADIs using the standard method

Table 14: Market risk - disclosures for ADIs using the IMA for trading portfolios

• Qualitative disclosures (a) The general qualitative disclosure requirement (refer to paragraph 3 of this Attachment) for market risk including the portfolios covered by the IMA. In addition, a discussion of the extent of, and methodologies for, compliance with the prudential requirements for prudent valuation practices for positions held in the trading book contained in Attachment A of APS 111.
• (b) The discussion must include an articulation of the soundness standards on which the ADI’s internal capital adequacy assessment is based. It should also include a description of the methodologies used to achieve a capital adequacy assessment that is consistent with the soundness standards.
• (c) For each portfolio covered by the IMA:• the characteristics of the models used;• a description of stress testing applied to the portfolio; and• a description of the approach used for back-testing/validating the accuracy and consistency of the internal models and modelling processes.
• (d) The scope of acceptance by APRA.
• (e) For the incremental risk capital charge and the comprehensive risk capital charge the methodologies used and the risks measured through the use of internal models. Included in the qualitative description must be:• the approach used by the ADI to determine liquidity horizons;• the methodologies used to achieve a capital assessment that is consistent with the required soundness standard; and• the approaches used in the validation of the models.
• Quantitative disclosures (f) For trading portfolios under the IMA:• the high, mean and low value-at-risk (VaR) values over the reporting period and period end; • the high, mean and low stressed VaR values over the reporting period and period-end;• the high. mean and low incremental and comprehensive risk capital charges over the reporting period and period-end; and• a comparison of VaR estimates with actual gains/losses experienced by the ADI, with analysis of important ‘outliers’ identified in back-test results.

 

Operational risk disclosures

6.             An ADI must disclose the items in Table 15, to the extent applicable.

Table 15: Operational risk

• Qualitative disclosures (a) In addition to the general qualitative disclosure requirement (refer to paragraph 3 of this Attachment), the approach(es) for operational risk capital assessment for which the ADI qualifies.
• (b) Description of the AMA used by the ADI, including a discussion of relevant internal and external factors considered in the ADI’s measurement approach. In the case of partial use, the scope and coverage of the different approaches used.
• (c) For ADIs using the AMA, a description of the use of insurance for the purpose of mitigating operational risk.

 

Equities

7.             An ADI must disclose the items in Table 16, to the extent applicable.

Table 16: Equities - disclosures for banking book positions

• Qualitative disclosures (a) The general qualitative disclosure requirement (refer to paragraph 3 of this Attachment) with respect to equity risk, including:• differentiation between holdings on which capital gains are expected and those taken under other objectives including for relationship and strategic reasons; and• discussion of important policies covering the valuation and accounting of equity holdings in the banking book. This includes the accounting techniques and valuation methodologies used, including key assumptions and practices affecting valuation as well as significant changes in these practices.
• Quantitative disclosures (b) Value disclosed in the balance sheet of investments, as well as the fair value of those investments; for quoted securities, a comparison to publicly quoted share values where the share price is materially different from fair value.
• (c) The types and nature of investments, including the amount that can be classified as:• publicly traded; and• privately held.
• (d) The cumulative realised gains (losses) arising from sales and liquidations in the reporting period.
• (e) Total unrealised gains (losses).Total latent revaluation gains (losses).Any amounts of the above included in Common Equity Tier 1, Tier 1 and/or Tier 2 capital.
• (f) Capital requirements (in terms of risk-weighted assets) and aggregate amounts broken down into appropriate equity asset classes.

 

Interest rate risk in the banking book

8.             An ADI must disclose the items in Table 17, to the extent applicable.

Table 17: Interest rate risk in the banking book

Attachment E

Leverage ratio disclosure requirements

1. An IRB ADI must complete and disclose Table 18 to the extent applicable.

 

Table 18: Leverage ratio disclosure template

 

• Item A$m
• On-balance sheet exposures
• 1 On-balance sheet items (excluding derivatives and securities financing transactions (SFTs), but including collateral)
• 2 (Asset amounts deducted in determining Tier 1 capital)
• 3 Total on-balance sheet exposures (excluding derivatives and SFTs) (sum of rows 1 and 2)
• Derivative exposures
• 4 Replacement cost associated with all derivatives transactions (i.e. net of eligible cash variation margin)
• 5 Add-on amounts for potential future credit exposure (PFCE) associated with all derivatives transactions
• 6 Gross-up for derivatives collateral provided where deducted from the balance sheet assets pursuant to the Australian Accounting Standards
• 7 (Deductions of receivables assets for cash variation margin provided in derivatives transactions)
• 8 (Exempted central counterparty (CCP) leg of client-cleared trade exposures)
• 9 Adjusted effective notional amount of written credit derivatives
• 10 (Adjusted effective notional offsets and add-on deductions for written credit derivatives)
• 11 Total derivative exposures (sum of rows 4 to 10)
• SFT exposures
• 12 Gross SFT assets (with no recognition of netting), after adjusting for sales accounting transactions
• 13 (Netted amounts of cash payables and cash receivables of gross SFT assets)
• 14 CCR exposure for SFT assets
• 15 Agent transaction exposures
• 16 Total SFT exposures (sum of rows 12 to 15)
• Other off-balance sheet exposures
• 17 Off-balance sheet exposure at gross notional amount
• 18 (Adjustments for conversion to credit equivalent amounts)
• 19 Other off-balance sheet exposures (sum of rows 17 and 18)
• Capital and total exposures
• 20 Tier 1 Capital
• 21 Total exposures (sum of rows 3, 11, 16 and 19)
• Leverage ratio %
• 22 Leverage ratio

 

Guidelines for the leverage ratio disclosure template

 

2.             In completing Table 18, an IRB ADI must have regard to Table 18A, which sets out an explanation of each row of Table 18.

Table 18A: Explanatory table for the leverage ratio disclosure template

 

• Explanation of each row of the leverage ratio disclosure template
• Row number Explanation
• 1 On-balance sheet assets according to paragraphs 5 and 6 in Attachment D to APS 110.
• 2 Deductions from Tier 1 Capital excluded from the leverage ratio exposure measure in accordance with paragraph 5(b) of Attachment D to APS 110, reported as a negative amount.
• 3 Sum of rows 1 and 2.
• 4 Replacement cost (RC) associated with all derivatives transactions (including exposures resulting from transactions described in paragraph 16 of Attachment D to APS 110), net of cash variation margin received and with, where applicable, bilateral netting according to paragraphs 9 and 14 of Attachment D to APS 110.
• 5 PFCE add-on amount for all derivative exposures according to paragraphs 9 and 10 of Attachment D to APS 110.
• 6 Grossed-up amount for collateral provided in accordance with paragraph 12 of Attachment D to APS 110.
• 7 Deductions of receivables assets from cash variation margin provided in derivatives transactions in accordance with paragraph 14(b) of Attachment D to APS 110, reported as negative amounts.
• 8 Exempted trade exposures associated with the CCP leg of derivatives transactions resulting from client-cleared transactions in accordance with paragraph 15 of Attachment D to APS 110, reported as negative amounts.
• 9 Adjusted effective notional amount (i.e. the effective notional amount reduced by any negative change in fair value) for written credit derivatives in accordance with paragraph 18(a) of Attachment D to APS 110.
• 10 Adjusted effective notional offsets of written credit derivatives in accordance with paragraph 18(b) of Attachment D to APS 110 and deducted add-on amounts relating to written credit derivatives in accordance with paragraph 20 of Attachment D to APS 110, reported as negative amounts.
• 11 Sum of rows 4-10.
• 12 Gross SFT assets with no recognition of any netting other than novation with qualifying central counterparties (QCCPs) in accordance with footnote 23 of Attachment D to APS 110, removing certain securities received in accordance with paragraph 22(a) of Attachment D to APS 110 and adjusting for any sales accounting transactions in accordance with paragraph 25 of Attachment D to APS 110.
• 13 Cash payables and cash receivables of gross SFT assets netted in accordance with paragraph 22(a) of Attachment D to APS 110, reported as negative amounts.
• 14 Measure of CCR for SFTs determined in accordance with paragraph 22(b) of Attachment D to APS 110.
• 15 Agent transaction exposure amount determined in accordance with paragraphs 26 to 28 of Attachment D to APS 110.
• 16 Sum of rows 12-15.
• 17 Total off-balance sheet exposure amounts on a gross notional basis, before any adjustment for credit conversion factors in accordance with paragraph 29 of Attachment D to APS 110.
• 18 Reduction in gross amount of off-balance sheet exposures due to the application of credit conversion factors in paragraph 29 of Attachment D to APS 110.
• 19 Sum of rows 17 and 18.
• 20 Tier 1 Capital in accordance with APS 111.
• 21 Sum of rows 3, 11, 16 and 19.
• 22 Leverage ratio in accordance with paragraph 1 of Attachment D to APS 110.

 

Summary comparison of accounting assets versus leverage ratio exposure measure

 

3.             An IRB ADI must complete and disclose Table 19 to the extent applicable.

Table 19: Summary comparison of accounting assets vs leverage ratio exposure measure

 

 

4.             An IRB ADI must complete and disclose Table 19 to the extent applicable. An ADI must disclose and detail the source(s) of material differences between its total balance sheet assets (net of on-balance sheet derivative and securities financing transaction assets) as reported in its audited financial statements and its on-balance sheet exposures in row 1 of Table 18 of this attachment.

5.             An IRB ADI must explain the key drivers of material changes in its leverage ratio from the end of the previous reporting period to the end of the current reporting period (whether these changes stem from changes in the numerator and/or from changes in the denominator).

6.             Where applicable, an IRB ADI must disclose the extent of assets held in a fiduciary capacity on the balance sheet that have been excluded from the exposure measure in accordance with APS 110 in Table 19 ‘Summary comparison of accounting assets vs leverage ratio exposure measure’.

 

Attachment F

Liquidity Coverage Ratio disclosure template

1. An LCR ADI[60] must complete and disclose the items in Table 20 to the extent applicable. 

Table 20: LCR disclosure template

 

• Total unweighted[61] value (average)(A$m) Total weighted[62] value (average)(A$m)

• Liquid assets, of which:

• 1 High-quality liquid assets (HQLA)

• 2 Alternative liquid assets (ALA)

• 3 Reserve Bank of New Zealand (RBNZ) securities

• Cash outflows

• 4 Retail deposits and deposits from small business customers, of which:

• 5 stable deposits

• 6 less stable deposits

• 7 Unsecured wholesale funding, of which:

• 8 operational deposits (all counterparties) and deposits in networks for cooperative banks

• 9 non-operational deposits (all counterparties)

• 10 unsecured debt

• 11 Secured wholesale funding

• 12 Additional requirements, of which

• 13 outflows related to derivatives exposures and other collateral requirements

• 14 outflows related to loss of funding on debt products

• 15 credit and liquidity facilities

• 16 Other contractual funding obligations

• 17 Other contingent funding obligations

• 18 Total cash outflows

• Cash inflows

• 19 Secured lending (e.g. reverse repos)

• 20 Inflows from fully performing exposures

• 21 Other cash inflows

• 22 Total cash inflows

• Total adjusted[63] value

• 23 Total liquid assets

• 24 Total net cash outflows

• 25 Liquidity Coverage Ratio (%)

 

Guidelines for the LCR disclosure template

 

2.             Data in Table 20 must be calculated as simple averages of daily observations over the previous quarter (i.e. the average is calculated over a period of, typically, 90 days)[64]. APRA may permit an LCR ADI to calculate the data in Table 20 based on averages of monthly observations over the previous quarter until the first reporting period after 1 January 2017.

3.             An LCR ADI must publish the number of data points used in calculating the average figures in Table 20.

4.             In completing Table 20, an LCR ADI must have regard to Table 20A, which sets out an explanation of each row of Table 20.

Table 20A: Explanation of each row in the LCR disclosure template

 

• Explanation of each row of the LCR disclosure template
• Row number Explanation
• 1 Sum of all eligible HQLA, as defined in APS 210, before the application of any limits, excluding assets that do not meet the operational requirements and, where applicable, assets qualifying under alternative liquidity approaches.
• 2 ALA are made available in jurisdictions where there is insufficient supply of HQLA1 (or both HQLA1 and HQLA2) in the domestic currency to meet the aggregate demand of banks with significant exposures in the domestic currency in the LCR framework.
• 3 Liquid assets contained in the RBNZ’s Liquidity Policy – Annex: Liquid Assets – Prudential Supervision Department Document BS13A12.
• 4 Retail deposits and deposits from small business customers are the sum of stable deposits, less stable deposits and any other funding sourced from (i) natural persons and/or (ii) small business customers (as defined in paragraph and footnote 6 of Attachment A to APS 210, and paragraphs 117 to 120 of Prudential Practice Guide APG 210 Liquidity).
• 5 Stable deposits include deposits placed with an LCR ADI by a natural person and unsecured wholesale funding provided by small business customers, defined as ‘stable’ in APS 210.
• 6 Less stable deposits include deposits placed with an LCR ADI by a natural person and unsecured wholesale funding provided by small business customers, not defined as ‘stable’ in APS 210.
• 7 Unsecured wholesale funding is defined as those liabilities and general obligations from customers other than natural persons and small business customers that are not collateralised.
• 8 Operational deposits include deposits from other ADIs where those deposits are required for certain activities (i.e. clearing, custody or cash management activities). Deposits in institutional networks of cooperative banks include deposits of member institutions with the central institution or specialised central service providers.
• 9 Non-operational deposits are all other unsecured wholesale deposits, both insured and uninsured.
• 10 Unsecured debt includes all notes, bonds and other debt securities issued by the LCR ADI, regardless of the holder, unless the bond is sold exclusively in the retail market and held in retail accounts.
• 11 Secured wholesale funding is defined as all collateralised liabilities and general obligations.
• 12 Additional requirements include other off-balance sheet liabilities or obligations.
• 13 Outflows related to derivative exposures and other collateral requirements include expected contractual derivatives cash flows on a net basis. These outflows also include increased liquidity needs related to: downgrade triggers embedded in financing transactions, derivative and other contracts; the potential for valuation changes on posted collateral securing derivatives and other transactions; excess non-segregated collateral held at the LCR ADI that could contractually be called at any time; contractually required collateral on transactions for which the counterparty has not yet demanded that the collateral be posted; contracts that allow collateral substitution to non-HQLA assets; and market valuation changes on derivatives or other transactions.
• 14 Outflows related to loss of funding on secured debt products include loss of funding on: asset-backed securities, covered bonds and other structured financing instruments; and asset-backed commercial paper, conduits, securities investment vehicles and other such financing facilities.
• 15 Credit and liquidity facilities include drawdowns on committed (contractually irrevocable) or conditionally revocable credit and liquidity facilities. The currently undrawn portion of these facilities is calculated net of any eligible HQLA if the HQLA have already been posted as collateral to secure the facilities or that are contractually obliged to be posted when the counterparty draws down the facility.
• 16 Other contractual funding obligations include contractual obligations to extend funds within a 30-day period and other contractual cash outflows not previously captured under APS 210.
• 17 Other contingent funding obligations, as defined in APS 210.
• 18 Total cash outflows: sum of rows 4–17.
• 19 Secured lending includes all maturing reverse repurchase and securities borrowing agreements.
• 20 Inflows from fully performing exposures include both secured and unsecured loans and other payments that are fully performing and contractually due within 30 calendar days from retail and small business customers and other wholesale customers.
• 21 Other cash inflows include derivatives cash inflows and other contractual cash inflows.
• 22 Total cash inflows: sum of rows 19–21.
• 23 Total liquid assets (after the application of any cap on HQLA2).
• 24 Total net cash outflows (after the application of any cap on cash inflows).
• 25 Liquidity Coverage Ratio (after the application of any cap on HQLA2 and caps on cash inflows).

 

 

 

Attachment G

Remuneration

1. An ADI must disclose the items in Tables 21 and 21A, to the extent applicable.

2.             The qualitative disclosures in Table 21 must be completed by reference to an ADI’s Remuneration Policy and any Board Remuneration Committee established under CPS 510.

3.             The quantitative disclosures in Tables 21 and 21A must be completed separately for senior managers and material risk-takers as defined in paragraph 21 of this Prudential Standard.

Table 21: Remuneration disclosure requirements

 

• Qualitative disclosures

• (a) Information relating to the bodies that oversee remuneration. Disclosures must include:

• the name, composition and mandate of the main body overseeing remuneration;

• the name of external consultants whose advice has been sought, the body by which they were commissioned, and in what areas of the remuneration process;

• a description of the scope of the ADI’s Remuneration Policy (e.g. by regions, business lines), including the extent to which it is applicable to foreign subsidiaries and branches; and

• a description of the types of persons considered as material risk takers and as senior managers as defined in paragraph 21 of this Prudential Standard, including the number of persons in each group.

• (b) Information relating to the design and structure of remuneration processes. Disclosures must include:

• an overview of the key features and objectives of remuneration policy;

• whether the Remuneration Committee reviewed the ADI’s Remuneration Policy during the past year, and if so, an overview of any changes that were made; and

• a discussion of how the ADI ensures that risk and financial control personnel (as defined in CPS 510) are remunerated independently of the businesses they oversee.

• (c) Description of the ways in which current and future risks are taken into account in the remuneration processes. Disclosures must include:

• an overview of the key risks that the ADI takes into account when implementing remuneration measures;

• an overview of the nature and type of the key measures used to take account of these risks, including risks difficult to measure (values need not be disclosed);

• a discussion of the ways in which these measures affect remuneration; and

• a discussion of how the nature and type of these measures has changed over the past year and reasons for the change, as well as the impact of changes on remuneration.

• (d) Description of the ways in which the ADI seeks to link performance during a performance measurement period with levels of remuneration. Disclosures must include:

• an overview of the main performance metrics for the ADI, top-level business lines and individuals;

• a discussion of how amounts of individual remuneration are linked to institution-wide and individual performance; and

• a discussion of the measures the ADI will in general implement to adjust remuneration in the event that performance metrics are weak.

• (e) Description of the ways in which the ADI seeks to adjust remuneration to take account of longer-term performance. Disclosures must include:

• a discussion of the ADI’s policy on deferral and vesting of variable remuneration and, if the fraction of variable remuneration that is deferred differs across persons or groups of persons, a description of the factors that determine the fraction and their relative importance; and

• a discussion of the ADI’s policy and criteria for adjusting deferred remuneration before vesting and after vesting through clawback arrangements.

• (f) Description of the different forms of variable remuneration that the ADI utilises and the rationale for using these different forms. Disclosures must include:

• an overview of the forms of variable remuneration offered (i.e., cash, shares and share-linked instruments and other forms); and

• a discussion of the use of the different forms of variable remuneration and, if the mix of different forms of variable remuneration differs across persons or groups of persons), a description the factors that determine the mix and their relative importance.

• Quantitative disclosures

• (g) - Number of meetings held by the main body overseeing remuneration during the financial year and the remuneration paid to its members.

• (h) - The number of persons having received a variable remuneration award during the financial year.

• Number and total amount of guaranteed bonuses awarded during the financial year.

• Number and total amount of sign-on awards made during the financial year.

• Number and total amount of termination payments made during the financial year.

• (i) - Total amount of outstanding deferred remuneration, split into cash, shares and share-linked instruments and other forms.

• Total amount of deferred remuneration paid out in the financial year.

• (j) - Breakdown of the amount of remuneration awards for the financial year in accordance with Table 18A below to show:− fixed and variable;− deferred and non-deferred; and− the different forms used (cash, shares and share-linked instruments and other forms).

• (k) Quantitative information about persons’ exposure to implicit (e.g. fluctuations in the value of shares or performance units) and explicit adjustments (e.g. malus, clawbacks or similar reversals or downward revaluations of awards) of deferred remuneration and retained remuneration:

• Total amount of outstanding deferred remuneration and retained remuneration exposed to ex post explicit and/or implicit adjustments.

• Total amount of reductions during the financial year due to ex post explicit adjustments.

• Total amount of reductions during the financial year due to ex post implicit adjustments.

 

 

Table 21A: Total value of remuneration awards for senior managers/material risk-takers

 

Attachment H

Disclosures for the identification of potential G-SIBs

1. If required by APRA, an ADI must disclose the indicators in Table 22.

2.             In completing Table 22, an ADI must disclose the reporting information identified in the reporting template for the end of year data collection exercise of the Macroprudential Supervision Group as issued by the Basel Committee in respect of the reporting year for the disclosure. The reporting information must be calculated in accordance with the reporting instructions issued by the Basel Committee in respect of the relevant reporting template.

 

Table 22: Disclosures for the identification of potential G-SIBs

 

• Size Current reporting year value(A$m)
• 1 Total exposures
• Interconnectedness
• 2 Intra-financial system assets
• 3 Intra-financial system liabilities
• 4 Securities outstanding
• Substitutability/ financial institution infrastructure
• 5 Payments made in the reporting year (excluding intragroup payments)
• 6 Assets under custody
• 7 Underwritten transactions in debt and equity markets
• Complexity
• 8 Notional amount of over-the-counter (OTC) derivatives
• 9 Trading and available-for-sale securities
• 10 Level 3 assets
• Cross-Jurisdictional Activity
• 11 Cross-jurisdictional claims
• 12 Cross-jurisdictional liabilities

 

 

 

Attachment I

Frequency and timing of disclosure requirements

Table 23: Frequency of disclosure requirements

 

• Quarterly Semi-annually Annually Same frequency as an ADI’s financial reports under the Corporations Act Continuously (as changes occur)
• Capital disclosures
• Attachment A – Capital disclosure template ✓
• Attachment B – Main features of capital instruments ✓
• Regulatory Capital reconciliation ✓
• Risk exposure and assessment disclosures
• Attachment C – Risk exposures and assessment (all ADIs) ✓
• Attachment D – Risk exposures and assessment (ADIs with IRB and AMA approval) ✓[65] ✓[66]
• Leverage ratio disclosures
• Attachment E – Leverage ratio tables ✓
• Paragraph 47 – Tier 1 Capital, Total exposures and leverage ratio ✓
• Liquidity Coverage Ratio disclosures
• Attachment F – Liquidity Coverage Ratio disclosure template ✓
• Remuneration disclosures
• Attachment G – Remuneration ✓
• Disclosures for the identification of potential G-SIBs
• Attachment H – Disclosures for the identification of potential G-SIBs template ✓

 

Table 24: Timing of disclosure requirements

 

• Concurrently with the lodgement of an ADI’s financial reports under the Corporations Act Within three months of lodgement of an ADI’s annual financial report under the Corporations Act Not later than 31 July following the date on which the indicators are based Continuously
• Capital disclosures
• Attachment A – Capital disclosure template ✓
• Attachment B – Main features of capital instruments ✓
• Regulatory Capital reconciliation ✓
• Risk exposure and assessment disclosures
• Attachment C – Risk exposures and assessment (all ADIs) ✓[67]
• Attachment D – Risk exposures and assessment (ADIs with IRB and AMA approval) ✓
• Leverage ratio disclosures
• Attachment E – Leverage ratio disclosure tables ✓
• Paragraph 47 – Tier 1 Capital, Total exposures and leverage ratio ✓[68]
• Liquidity Coverage Ratio disclosures
• Attachment F – Liquidity Coverage Ratio disclosure template ✓
• Remuneration disclosures
• Attachment G – Remuneration ✓
• Disclosures for the identification of potential G-SIBs
• Attachment H – Disclosures for the identification of potential G-SIBs template ✓

 

---

[1]  Other than a foreign ADI – refer to paragraph 9(q).

[2]  APRA will publish on its website a current list of those ADIs required to make the disclosures required in Attachment H.

[3]  Where the disclosures required to be made under paragraph 47 do not coincide with the lodgement of an ADI’s financial report under the Corporations Act, the disclosures must be included in the Regulatory Disclosures section of the ADI’s website. 

[4]  See paragraph 33 above.

[5]  See paragraph 33 above.

[6]  See paragraph 39 above.

[7]  See paragraph 39 above.

[8]  See paragraph 39 above.

[9]  However, an ADI may, subject to APRA’s approval, use more frequent calculations (e.g. daily or monthly averaging) on a consistent basis.

[10]  For the avoidance of doubt, an ADI is not required to publish figures for any of the previous three quarters that were not previously disclosed under paragraph 47. 

[11]  See paragraph 39 above.

[12]   However, APRA may permit an ADI whose financial year ends on 30 June to make the disclosures required in Attachment H as at 31 December (i.e. based on interim rather than financial year-end data).

[13]  Refer to subsection 11AF(2) of the Act.

[14]  For standardised portfolios: claims secured by residential mortgage; other retail; corporate; bank; government; and all other; and for IRB portfolios: corporate; sovereign; bank; residential mortgage; qualifying revolving retail; other retail; and all other.

[15]  Table 4 does not include equities or securitisation exposures.

[16]  This breakdown could be in line with normal accounting rules (e.g. loans; commitments and other non-market off-balance sheet exposures; debt securities; and over-the-counter derivatives).

[17]  Refer to footnote 16.

[18]  Refer to footnote 16.

[19]  Securitisation exposures include but are not restricted to, securities, liquidity facilities, protection provided to securitisation positions, other commitments and credit enhancements such as cash collateral and other subordinated assets. Refer to Prudential Standard APS 120 Securitisation (APS 120).

[20]  As defined in Prudential Standard APS 112 Capital Adequacy: Standardised Approach to Credit Risk (APS 112).

[21]  Table 7 does not include equities or securitisation exposures.

[22]  This breakdown could be in line with normal accounting rules (e.g. loans; commitments and other non-market off-balance sheet exposures; debt securities; and over-the-counter derivatives).

[23]  Geographical areas may comprise individual countries, groups of countries or regions within countries. An ADI might choose to define the geographical areas based on the way its portfolio is geographically managed. The criteria used to allocate the loans to geographical areas must be specified.

[24]  ADIs are encouraged also to provide an analysis of the aging of loans that are past due.

[25]  The reconciliation shows separately specific provisions and the general reserve for credit losses; the information comprises: a description of the type of provision/reserve; the opening balances; write-offs taken during the period; amounts set aside (or reversed) for estimated probable loan losses during the period, any other adjustments (e.g. exchange rate differences, business combinations, acquisitions and disposals of subsidiaries), including transfers between provisions and reserves; and the closing balances. Write-offs and recoveries that have been recorded directly to the income statement must be disclosed separately.

[26]  This information need not be disclosed if the ADI complies with a standard mapping published by APRA.

[27]  Table 9 does not include equities or securitisation exposures.

[28]  In both the qualitative disclosures and quantitative disclosures that follow, an ADI must distinguish between the qualifying revolving retail exposures and other retail exposures unless these portfolios are insignificant in size (relative to overall credit exposures) and the risk profile of each portfolio is sufficiently similar such that separate disclosure would not help users’ understanding of the risk profile of the ADI’s retail business.

[29]  This disclosure does not require a detailed description of the model in full – it must provide a broad overview of the model approach, describing definitions of the variables, and methods for estimating and validating those variables set out in the quantitative risk disclosures below. This must be done for each of the portfolios. The ADI must draw out any significant differences in approach to estimating these variables within each portfolio.

[30]  The PD, LGD and EAD disclosures below must reflect the effects of collateral, netting and guarantees/credit derivatives as applicable.

[31]  Outstanding loans and EAD on undrawn commitments can be presented on a combined basis for these disclosures.

[32]  An ADI need only provide one estimate of EAD for each portfolio. However, where an ADI believes it is helpful, in order to give a more meaningful assessment of risk, they may also disclose EAD estimates across a number of EAD categories, against the undrawn exposures to which these relate.

[33]  An ADI would normally be expected to follow the disclosures provided for the non-retail portfolios. However, an ADI may choose to adopt EL grades as the basis of disclosure where they believe this can provide the reader with a meaningful differentiation of credit risk. Where an ADI is aggregating internal grades (either PD/LGD or EL) for the purposes of disclosure, this must be a representative breakdown of the distribution of those grades used in the IRB approach.

[34]  These disclosures are a way of further informing about the reliability of the information provided in the ‘quantitative disclosures: risk assessment’ over the long run.

[35]  An ADI is expected to provide these disclosures for as long run of data as possible – for example, if the ADI has 10 years of data, it might choose to disclose the average default rates for each PD grade over that 10-year period. Annual amounts need not be disclosed.

[36]  An ADI must provide this further decomposition where it will allow users greater insight into the reliability of the estimates provided in Table 9(d) ‘Quantitative disclosures: risk assessment’. In particular, an ADI must provide this information where there are material differences between the PD, LGD or EAD estimates given by it compared to actual outcomes over the long run. The ADI must also provide explanations for such differences.

[37]  At a minimum, an ADI must provide the disclosures in this table in relation to credit risk mitigation that has been recognised for the purposes of reducing capital requirements under APS 112 and Prudential Standard APS 113 Capital Adequacy: Internal Ratings-based Approach to Credit Risk (APS 113). Where relevant, an ADI is encouraged to give further information about mitigants that have not been recognised for that purpose. Credit derivatives and other credit risk mitigation that are treated as part of synthetic securitisation structures must be excluded from the credit risk mitigation disclosures and included within those relating to securitisation (Table 12).

[38]  If the comprehensive approach is applied, where applicable, the total exposure covered by collateral after haircuts must be reduced further to remove any positive adjustments that were applied to the exposure as permitted under APS 112 and APS 113.

[39]  Net credit exposure is the credit exposure on derivatives transactions after considering both the benefits from legally enforceable netting agreements and collateral arrangements.             

[40]  For example, interest rate contracts, foreign exchange contracts, equity contracts, credit derivatives, and commodity/other contracts.

[41]  For example, Credit Default Swaps, Total Return Swaps, Credit options, and other.

[42]  Where relevant, an ADI is encouraged to differentiate between securitisation exposures resulting from activities in which they are an originating ADI and exposures that result from all other securitisation activities that are subject to APS 120. An originating ADI is also encouraged to distinguish between situations where it originates underlying exposures included in a securitisation from those where it is either a managing ADI (of a third party securitisation) or provider of a facility (other than derivatives) to an asset-backed commercial paper securitisation.

[43]  Where relevant, an ADI must provide separate qualitative disclosures for banking book and trading book exposures.

[44]  For example, if an ADI is particularly active in the market of senior tranches of re-securitisations of mezzanine tranches related to securitisations of residential mortgages, it must describe the ‘layers’ of re-securitisations (i.e. senior tranche of mezzanine tranche of residential mortgage); this description must be provided for the main categories of re-securitisation products in which the ADI is significantly active.

[45]  For example, originator, investor, servicer, provider of credit enhancement, sponsor, liquidity provider, swap provider, protection provider.

[46]  Refer to footnote 19.

[47]  An ADI would generally be considered a ‘sponsor’ if it, in fact or in substance, manages or advises the programme, places securities into the market, or provides liquidity and/or credit enhancements. The programme may include, for example, ABCP conduit programmes and structured investment vehicles.

[48]  Where relevant, ADIs are encouraged to differentiate between valuation of securitisation exposures and resecuritisation exposures.

[49]  For example, credit cards, home equity, auto, and securitisation exposures detailed by underlying exposure type and security type (e.g. Residential Mortgage-backed Securities (RMBS), Commercial Mortgage-backed Securities (CMBS), Asset-backed Securities (ABS), Collateralised Debt Obligations (CDOs), etc.

[50]  ‘Exposures securitised’ include underlying exposures originated by the ADI, whether generated by it or purchased into the balance sheet from third parties, and third-party exposures included in sponsored schemes. Securitisation transactions (including underlying exposures originally on the ADI’s balance sheet and underlying exposures acquired by the ADI from third-party entities) in which the originating ADI does not retain any securitisation exposure must be shown separately but need only be reported for the year of inception. 

[51]  An ADI is required to disclose exposures regardless of whether there is a capital charge under APS 120.

[52]  For example, charge-offs/allowances (if the assets remain on the ADI’s balance sheet) or write-downs of retained residual interests, as well as recognition of liabilities for probable future financial support required of the ADI with respect to securitised assets.

[53]  Refer to footnote 50.

[54]  Refer to footnote 19.

[55]  Refer to APS 111.

[56]  Separate disclosures are required for the capital requirements on securitisation positions under Table 12.

[57]  See paragraph 7 in Attachment D to APS 110

[58]  This should show the credit equivalent amount of off-balance sheet items according to paragraph 30 in Attachment D to APS 110

[59]  This should be the sum of the previous items and should be consistent with row 21 of Table 18.

[60]  Other than a foreign ADI; refer to paragraph 9(q) of this Prudential Standard.

[61]  Unweighted values must be calculated as outstanding balances maturing or callable within 30 days (for inflows and outflows).

[62]  Weighted values must be calculated after the application of respective haircuts (for HQLA) or inflow and outflow rates (for inflows and outflows).

[63]  Adjusted values must be calculated after the application of both (i) haircuts and inflow and outflow rates and (ii) any applicable caps (i.e. cap on HQLA2 and cap on inflows).

[64]  For LCR ADIs reporting on a semi-annual basis, the average LCR must be reported for each of the two preceding quarters. For LCR ADIs reporting on an annual basis, the LCR must be reported for each of the preceding four quarters.

[65]  Quantitative disclosures

[66]  Qualitative disclosures

[67]  Or within 40 business days after the end of the period to which the disclosure relates for any quarterly period that does not coincide with the lodgement of an ADI’s financial report under the Corporations Act.

[68]  Or within 40 business days after the end of the period to which the disclosure relates for any quarterly period that does not coincide with the lodgement of an ADI’s financial report under the Corporations Act.